Eli Lilly has been a growth beast in recent years, but its valuation has gotten fairly high along the way.

Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) researches, develops, and markets medicines across cardiometabolic disease, oncology, immunology, neuroscience, and beyond. With a ...

Eli Lilly and Company (NYSE:LLY) is included in the list of the best performing S&P 500 stocks in the last five years. As of February 6, 2026, robust demand for the company’s obesity and diabetes ...

Shares of Eli Lilly & Co. LLY slid 3.23% to $1,017.97 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.04% to 6,881.62 and the ...

Eli Lilly advances CRISPR collaboration with Scribe Therapeutics for neurological and neuromuscular disorders; European ...

Eli Lilly operates in the healthcare sector as a global pharmaceutical manufacturer with commercial medicines and a broad research portfolio across immunology, oncology, and metabolic health. Eli ...

Eli Lilly and Company (NYSE:LLY) shares are up on Monday as the company benefits from positive market sentiment following ...

Looking into the current session, Eli Lilly and Co Inc. (NYSE:LLY) shares are trading at $1029.05, after a 7.05% drop. Over the past month, the stock decreased by 5.17%, but over the past year, it ...

Eli Lilly and Co. (NYSE:LLY) on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for ...

Shares of Eli Lilly & Co. LLY slid 1.28% to $1,028.83 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.81% to 6,946.13 and ...